Anna Modoni

The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass

Bone Morphogenetic Protein (BMP) signaling in development and human diseases

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Parkinson disease

Neurological sequelae of 2009 influenza A (H1N1) in children: A case series observed during a pandemic*

Nrf2-Keap1 signaling in oxidative and reductive stress

Pathological roles of MAPK signaling pathways in human diseases

Misregulation of Tau Alternative Splicing in Neurodegeneration and Dementia

The role of autophagy in neurodegenerative disease

Parkinson's disease: from monogenic forms to genetic susceptibility factors

Ageing as a risk factor for neurodegenerative disease

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Cell Biology of Ischemia/Reperfusion Injury

MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011

Autophagy: Renovation of Cells and Tissues

Tau in physiology and pathology

Prevalence of Muscular Dystrophies: A Systematic Literature Review

Mitochondria: In Sickness and in Health

Parkinson's disease

The myotonic dystrophies: diagnosis and management

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation

Autoantibodies associated with diseases of the CNS: new developments and future challenges

Mitochondria: The Next (Neurode)Generation

Physiological Roles of Mitochondrial Reactive Oxygen Species

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)

Common micro‐RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System

Andersen–Tawil syndrome: Clinical and molecular aspects

Immune-mediated pathology in Duchenne muscular dystrophy

Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease

Regulation of Mammalian Autophagy in Physiology and Pathophysiology

An Italian family with inclusion‐body myopathy and frontotemporal dementia due to mutation in the VCP gene

Single-fiber PCR in MELAS3243 patients: Correlations between intratissue distribution and phenotypic expression of the mtDNAA3243G genotype

Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients

Lack of Any Cardiac Involvement in a Patient with Andersen-Tawil Syndrome Associated with the c.574A→G Mutation in <i>KCNJ2</i>

Successful Treatment of Acute Autoimmune Limbic Encephalitis With Negative VGKC and NMDAR Antibodies

DJ‐1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7

A new mtDNA mutation associated with a progressive encephalopathy and cytochrome c oxidase deficiency

Characterization of the Pattern of Cognitive Impairment in Myotonic Dystrophy Type 1

Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression